Warburg Pincus and Lendlease complete life sciences real estate JV

Each partner will contribute 50% of the co-investment capital over the next few years.

Global growth investor Warburg Pincus and Australian real estate group Lendlease have announced the final closing of a new joint venture focused on life sciences real estate. 

Each partner will contribute 50% of the co-investment capital over the next few years, aiming to establish a multi-billion-dollar platform through attracting third-party investors and additional capital.

The newly formed platform, headquartered in Singapore, will concentrate on investing, acquiring, developing, constructing, managing, and operating real estate projects within the rapidly expanding life sciences and R&D sectors across Asia Pacific.

The joint venture will leverage the extensive sector expertise and market experience of both Warburg Pincus and Lendlease. It is designed to become a leading force in the life sciences and R&D real estate markets in the region.

The platform is initially seeded with two of Lendlease’s existing businesses, including a high-barrier life sciences project construction management business and a specialised investment management business. Its first investment vehicle, LINO, currently holds the Leaf Minatomirai, a 24,000 square meter R&D workplace in Yokohama, which has recently undergone an asset enhancement initiative.